The FDA has approved Kite Pharma's Tecartus as a treatment for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL), making CAR-T therapy an option for an entirely ...
Custom Cursor & Fixed Background body { margin: 0; min-height: 100vh; background-image: url(' background-size: cover; background-repeat: no-repeat; background-position: center; background-attachment: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results